Back to Browse Journals » Reports in Medical Imaging » Volume 2

Comparison of a new PillCam™ SB2 video capsule versus the standard PillCam™ SB for detection of small bowel disease

Authors Yoav C Metzger, Samuel N Adler, Ariella Bar-Gil Shitrit, Binyamin Koslowsky, Ingvar Bjarnason

Published Date February 2009 Volume 2009:2 Pages 7—11

DOI http://dx.doi.org/10.2147/RMI.S4227

Published 8 February 2009

Yoav C Metzger1, Samuel N Adler2, Ariella Bar-Gil Shitrit3, Binyamin Koslowsky4, Ingvar Bjarnason5

1School of Medicine, Hebrew University of Jerusalem, Israel; 2Department of Gastroenterology, Bikur Holim Hospital, Jerusalem, Israel; 3Department of Gastroenterology, Shaare Zedek Medical Center, Jerusalem, Israel; 4Department of Medicine, Hadassah Medical Organization, Jerusalem, Israel; 5Department of Gastroenterology, King’s College Hospital, London, UK

Background: Capsule endoscopy is the procedure of choice for many suspected small bowel diseases. PillCam™ small bowel (SB), has a high diagnostic yield. No improvements have been made on its optics since its introduction in 2002.

Aim: To compare the diagnostic yield and quality of visualization of PillCam™ SB with that of a new small bowel endoscope (PillCam™ SB2) which has a larger angle of view and upgraded visual attributes.

Methods: Twenty patients were randomized to undergo capsule enteroscopy with PillCam™ SB and PillCam™ SB2 a week apart.

Results: Both procedures had a comparable diagnostic yield. However images from PillCam™ SB2 were found to be significantly better in regards of homogenous light exposure (P < 0.001), sharpness and resolution (P < 0.001), depth of view (P < 0.005), and overall impression (P < 0.0001).

Conclusion: PillCam™ SB2 appears to be superior to the original PillCam™ SB in regard to quality of images obtained.

Keywords: small bowel, capsule endoscopy, image quality, resolution

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Nanomedicine strategies for treatment of secondary spinal cord injury

White-Schenk D, Shi R, Leary JF

International Journal of Nanomedicine 2015, 10:923-938

Published Date: 29 January 2015

Real-world effectiveness of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in high-risk patients and other subgroups

Assaad-Khalil SH, Najem R, Sison J, Kitchlew AR, Cho BL, Ueng KC, DiTommaso S, Shete A

Vascular Health and Risk Management 2015, 11:71-78

Published Date: 21 January 2015

Bio-functionalized dense-silica nanoparticles for MR/NIRF imaging of CD146 in gastric cancer

Wang P, Qu Y, Li C, Yin L, Shen C, Chen W, Yang S, Bian X, Fang D

International Journal of Nanomedicine 2015, 10:749-763

Published Date: 20 January 2015

Vincristine sulfate liposomal injection for acute lymphoblastic leukemia [Corrigendum]

Soosay Raj TA, Smith AM, Moore AS

International Journal of Nanomedicine 2013, 8:4705-4706

Published Date: 5 December 2013

Corrigendum

Schneider EW, Johnson MW

Clinical Ophthalmology 2011, 5:1315-1316

Published Date: 16 September 2011

Intracellular heavy metal nanoparticle storage: progressive accumulation within lymph nodes with transformation from chronic inflammation to malignancy

Tommaso Iannitti, Stefania Capone, Antonietta Gatti, et al

International Journal of Nanomedicine 2010, 5:955-960

Published Date: 15 November 2010

The economic impact of obesity in the United States

Ross A Hammond, Ruth Levine

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:285-295

Published Date: 30 August 2010

Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity

Joseph Finkelstein, Eunme Cha, Steven M Scharf

International Journal of Chronic Obstructive Pulmonary Disease 2009, 4:337-349

Published Date: 4 September 2009

30-days mortality in patients with perforated peptic ulcer: A national audit

Anne Nakano, Jørgen Bendix, Sven Adamsen, Daniel Buck, Jan Mainz, et al

Risk Management and Healthcare Policy 2008, 1:31-38

Published Date: 30 November 2008